Article thumbnail

Differential Regulation of the Excitability of Prefrontal Cortical Fast-Spiking Interneurons and Pyramidal Neurons by Serotonin and Fluoxetine

By Ping Zhong and Zhen Yan

Abstract

Serotonin exerts a powerful influence on neuronal excitability. In this study, we investigated the effects of serotonin on different neuronal populations in prefrontal cortex (PFC), a major area controlling emotion and cognition. Using whole-cell recordings in PFC slices, we found that bath application of 5-HT dose-dependently increased the firing of FS (fast spiking) interneurons, and decreased the firing of pyramidal neurons. The enhancing effect of 5-HT in FS interneurons was mediated by 5-HT2 receptors, while the reducing effect of 5-HT in pyramidal neurons was mediated by 5-HT1 receptors. Fluoxetine, the selective serotonin reuptake inhibitor, also induced a concentration-dependent increase in the excitability of FS interneurons, but had little effect on pyramidal neurons. In rats with chronic fluoxetine treatment, the excitability of FS interneurons was significantly increased, while pyramidal neurons remained unchanged. Fluoxetine injection largely occluded the enhancing effect of 5-HT in FS interneurons, but did not alter the reducing effect of 5-HT in pyramidal neurons. These data suggest that the excitability of PFC interneurons and pyramidal neurons is regulated by exogenous 5-HT in an opposing manner, and FS interneurons are the major target of Fluoxetine. It provides a framework for understanding the action of 5-HT and antidepressants in altering PFC network activity

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3044712
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1991). 5-Hydroxytryptamine-2 and 5-hydroxytryptamine-1A receptors mediate opposing responses on membrane excitability in rat association cortex.
  2. (1999). A review of central 5-HT receptors and their function.
  3. (1999). Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex.
  4. (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat.
  5. (1995). Cellular basis of working memory.
  6. (2004). Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
  7. (2004). Coexpression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex.
  8. (2006). Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice.
  9. (2005). Cortical inhibitory neurons and schizophrenia.
  10. (2000). Destruction and creation of spatial tuning by disinhibition: GABAA blockade of pre-frontal cortical neurons engaged by working memory.
  11. (2003). Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex.
  12. DrevetsWC,PriceJL,SimpsonJr.JR,ToddRD,ReichT,etal.(1997) Subgenual prefrontal cortex abnormalities in mood disorders.
  13. (1992). Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain.
  14. (2003). Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex.
  15. (2004). Endogenous Glucocorticoids Are Essential for Maintaining Prefrontal Cortical Cognitive Function.
  16. (2004). Expression of 5-HT1A and 5-HT2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.
  17. (1997). GABAergic cell subtypes and their synaptic connections in rat frontal cortex.
  18. (2001). Gutie ´rrez-Garcı ´a AG, Bernal-Morales B
  19. (2008). Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder.
  20. (2003). Impaired modulation of GABAergic transmission by muscarinic receptors in a mouse transgenic model of Alzheimer’s disease.
  21. (2003). Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide.
  22. (2008). In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
  23. (2003). Interneuron diversity series: inhibitory interneurons and network oscillations in vitro.
  24. (2007). Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex.
  25. (2001). Modeling panic attacks.
  26. (2008). Modulation of neuronal excitability by serotonin-NMDA interactions in prefrontal cortex.
  27. (1997). Molecular and physiological diversity of cortical nonpyramidal cells.
  28. (1999). Monoamine oxidase A inhibition by fluoxetine: an in vitro and in vivo study.
  29. (1997). Neurobiology of serotonin in depression and suicide.
  30. (1999). Neuronal synchrony: a versatile code for the definition of relations?
  31. (1994). Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow.
  32. (2002). Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents.
  33. (2009). Pascual-Leone A
  34. (1995). Prozac (fluoxetine, Lilly 110140), the first selective serotonin reuptake inhibitor and an antidepressant drug: twenty years since its first publication.
  35. (2001). Receptor-mediated inhibition of G protein-coupled inwardly rectifying potassium channels involves G(alpha)q family subunits, phospholipase C, and a readily diffusible messenger.
  36. (2007). Reduced 5-HT1A- and GABAb receptor function in dorsal raphe neurons upon chronic fluoxetine treatment of socially stressed rats.
  37. (1998). Regulation of membrane excitability in the central nervous system by serotonin receptor subtypes.
  38. (2000). Rhe prefrontal cortex and cognitive control.
  39. (2004). Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A,5 - H T 2A,a n d 5-HT7 receptors.
  40. (2000). Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat.
  41. (1997). Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.
  42. (2003). Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development.
  43. (2007). Serotonin inhibits neuronal excitability by activating two-pore domain k+ channels in the entorhinal cortex.
  44. (2010). Serotonin modulates fast-spiking interneuron and synchronous activity in the rat Effects of 5-HT in Different
  45. (1996). Serotonin modulates N- and P-type calcium currents in neocortical pyramidal neurons via a membrane-delimited pathway.
  46. (2001). Serotonin receptors modulate GABA(A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons.
  47. (2003). Serotonin reduces the hyperpolarization-activated current (Ih) in ventral tegmental area dopamine neurons: involvement of 5-HT2 receptors and protein kinase C.
  48. (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.
  49. (1992). Structure and function of brain serotonin systems.
  50. (2007). Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks.
  51. (2003). Synchronous neural oscillations and cognitive processes.
  52. (2006). T-Type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine.
  53. (1985). The pharmacologic profile of fluoxetine.
  54. (2002). The physiological role of 5-HT2A receptors in working memory.
  55. (2000). Timing of onset of antidepressant response with fluoxetine treatment.
  56. (1994). Working memory dysfunction in schizophrenia.